Covered recipient · General Payments record
CAROL H MILLER
Allopathic & Osteopathic Physicians Obstetrics & Gynecology
General Payments · PY2021–2024
$1,577.86
- Reported across 69 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $411.56 | 20 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $305.12 | 15 |
| Novo Nordisk AS | $69.21 | 3 |
| PFIZER INC. | $24.02 | 1 |
| SHIELD THERAPEUTICS INC | $13.21 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (20)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $19.69 | 01/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105035721 | CMS |
| ABBVIE INC. | $20.09 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105035723 | CMS |
| ABBVIE INC. | $22.33 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105035725 | CMS |
| ABBVIE INC. | $22.78 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105035727 | CMS |
| ABBVIE INC. | $26.37 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105035729 | CMS |
| ABBVIE INC. | $24.76 | 03/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105035731 | CMS |
| ABBVIE INC. | $24.00 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105035733 | CMS |
| ABBVIE INC. | $16.00 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105035735 | CMS |
| ABBVIE INC. | $12.34 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105035737 | CMS |
| ABBVIE INC. | $16.27 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105035739 | CMS |
| ABBVIE INC. | $19.23 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105035741 | CMS |
| ABBVIE INC. | $23.25 | 07/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105035743 | CMS |
| ABBVIE INC. | $22.80 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105035745 | CMS |
| ABBVIE INC. | $12.03 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105035747 | CMS |
| ABBVIE INC. | $23.18 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105035749 | CMS |
| Novo Nordisk Inc | $23.57 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096890985 | CMS |
| Novo Nordisk Inc | $15.96 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097079801 | CMS |
| Novo Nordisk Inc | $29.68 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096966443 | CMS |
| PFIZER INC. | $24.02 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131628264 | CMS |
| SHIELD THERAPEUTICS INC | $13.21 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150150057 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.